|
Pfizer is collaborating with governments and non-governmental organisations (NGOs) to donate its antifungal medicine, Diflucan® (fluconazole), to HIV/AIDS patients in the developing countries hardest hit by HIV/AIDS. Although not a cure for HIV/AIDS, Diflucan® is efficacious in treating two AIDS-related opportunistic infections: cryptococcal meningitis and oesophageal candidiasis. Through the Diflucan® Partnership Program, Pfizer is providing the medicine free of charge and without time limits to public health clinics for distribution to patients. Partners include Axios International, Interchurch Medical Assistance, and the International Association for Physicians in AIDS Care (IAPAC).
As of April 2005, Pfizer had donated more than 4 million free doses of Diflucan® to governments and NGOs operating in more than 1,000 sites in 34 countries, in Africa, Asia, the Caribbean and Latin America, and treated more than 150,000 patients. More than 20,000 health care providers have been trained through IAPAC in the countries participating in the program.
|
